Opyl

Opyl Signs New Service Agreement with Commercial Eyes

Opyl Limited (ASX: OPL) a leader in clinical trial design and biostatistical validation, is pleased to announce the signing of a service agreement with Commercial Eyes Pty Ltd, a ProductLife Group company and prominent Australian pharmaceutical and medical device commercialisation company.


Commercial Eyes is a leading lifesciences consultancy that offers full end-to-end commercialisation services. As part of ProductLife Group, an international leader in the life sciences industry, Commercial Eyes has expanded its global presence, enabling broader market access and expertise across the JAPAC region and beyond.

This collaboration will leverage global insights to enhance Commercial Eyes’ market research and competitive intelligence capabilities.

This agreement signifies a major milestone in Opyl's ongoing commitment to enhancing clinical trial outcomes through AI-driven solutions.

Under the terms of this agreement, Opyl will provide Commercial Eyes with market research, and competitive intelligence analysis to assist in a range of client projects, across the pharmaceutical, medtech and biotechnology sectors.

Key Highlights

  • AI-Driven Clinical Trial Information: The service agreement enables Commercial Eyes to utilise Opyl’s TrialKey platform, which provides data-backed recommendations and boasts over 92% accuracy in forecasting clinical trial outcomes.
  • Comprehensive Services: The paid partnership covers market research, and competitive intelligence analysis to support Commercial Eyes in offering strategic insights to its clients in the pharmaceutical and medical device sectors.
  • International Exposure: Commercial Eyes, as part of the ProductLife Group (PLG), extends Opyl’s reach to international markets, particularly across Europe and the JAPAC region.
  • Increased Domestic Exposure: The partnership also increases Opyl’s presence in the domestic market by leveraging Commercial Eyes’ strong reputation and client base within the Australian healthcare sector.
  • Strategic Market Positioning: TrialKey’s data analytics empower Commercial Eyes to navigate the complex trial landscape, providing their clients with informed, strategic guidance that enhance commercial positioning and success.

Click here for the full ASX Release

This article includes content from Opyl, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

OPL:AU
The Conversation (0)
Bigtincan Holdings Limited

Vector Capital Proposal Determined to be Superior Proposal Matching Rights Process Triggered

Further to its announcements on 30 October 2024 and 12 November 2024, Bigtincan Holdings Limited (Bigtincan) (ASX:BTH) has received a revised proposal from Vector Capital Management, L.P. (Vector) to acquire BTH by way of scheme of arrangement for cash consideration of 22 cents per share, which will be reduced (1) on a per share basis to the extent that BTH’s transaction costs in connection with the IAAC Transaction, the Vector Proposal and the director nominations at the 2024 AGM exceed $4 million, and (2) by 0.7 cents per share if the break fee becomes payable under the IAAC SID (Vector Proposal). BTH shareholders will be informed in due course should any adjustment be triggered.

Keep reading...Show less
Streamplay Studio

Streamplay Studio Enters into Agreement to Acquire North American Indie Gaming Leader, Noodlecake Studios

Streamplay Studio Limited (“Streamplay” or the “Company”) (ASX: SP8), is pleased to announce that it has entered into a binding Share Sale Agreement (“SSA”) to acquire 100% of Noodlecake Studios Inc. (“Noodlecake”), a profitable North American indie gaming company headquartered in Canada, from its parent company Zplay (HK) Technology Co. Limited (“Zplay”). The addition of Noodlecake aligns with Streamplay’s strategic direction, including the recent appointment of Silicon Valley tech advisor Paolo Privitera (ASX: 8 October 2024) to the board of directors, strengthening the Company’s North American and global gaming footprint.

Keep reading...Show less
HighCom Limited

HighCom Limited Receives A$5.6m SUAS Spare Parts Order from Defence

HighCom Limited (ASX: HCL, ‘HighCom’, ‘Group’) is pleased to announce that it has received a new spare parts order for A$5.6m (including GST) from the Commonwealth of Australia’s Department of Defence, as part of the Small Uncrewed Aerial Systems (SUAS) Support Contract. The order will be completed during H2 FY2025.

Keep reading...Show less
  FBR Limited

Next-generation Hadrian X® Completes US Site Acceptance Testing

Robotic technology company FBR Limited (ASX: FBR; OTCQB: FBRKF) (‘FBR’ or ‘the Company’) is pleased to announce that it has received confirmation from CRH Ventures that the first next-generation Hadrian X® has successfully met their requirements and has completed Site Acceptance Testing at the Fort Myers facility in Florida, United States.

Keep reading...Show less
Cypher Metaverse

Cypher Metaverse Inc. Announces Financing

Cypher Metaverse Inc. (CSE:CODE) ("CODE" or the "Company") is pleased to announce that it is undertaking a non-brokered private placement of up to $1,000,000. The Company will issue up to 11,764,705 units at a price of $0.085 per unit. Each unit consists of one common share and one common share warrant. Each warrant entitles the holder to subscribe for one additional common share for $0.15 for a period of 2 years from the date of closing, subject to the Corporation's option to accelerate the expiry date if the stock trades at $0.20 for 10 trading days.

The Company has completed the first closing of the private placement. The Company accepted subscriptions for 1,357,061 units at a price of $0.085 per unit, for gross proceeds of $115,350. Securities issued pursuant to this tranche are subject to trading restrictions until December 7, 2024.

Keep reading...Show less

Latest Press Releases

Related News

×